SWOT Analysis
- S
- W
- O
- T
Technical Analysis
Moving Averages
We appreciate your patience. Your content is on the way.
Current Price


- Bullish Moving Averages
- Bearish Moving Averages
Resistance and support
We appreciate your patience. Your content is on the way.
Company Financials
- Profit and loss statement
- Balance sheet
- Quarterly Result
- Ratio
We appreciate your patience. Your content is on the way.
Quick Results Snapshot
We appreciate your patience. Your content is on the way.
Stocks Comparison
Table
Chart
We appreciate your patience. Your content is on the way.
Corporate Action
- Announcement
- Board Meeting
- Dividend
- Split
- Rights
- Events
Insider & Institutional Activity
- Bulk Block Deals
- Insider Trading & SAST
We appreciate your patience. Your content is on the way.
About Ishita Drugs & Industries Ltd
Stock PE (TTM)
Promoter Holding
Book Value
ROCE
ROE
Ishita Drugs & Industries Limited was incorporated in Feb.`92 by Jagdish Agarwal. The Company is engaged in the manufacture of various Activa Pharma Ingredients, drug intermediates, fine chemicals and excipient. It has a state-of-art manufacturing facility, in terms of reaction capabilities, quality control and environmental safety. The plant has been designed and constructed to meet GMP norms. The genesis of the Ishita Group in 1992 was the result of the entrepreneurial spirit of Mr. Jagdish Agrawal, who set up a reactive dye manufacturing unit in Ahmedabad. Buoyed by the growth of its first Venture, the Group made its maiden foray in the pharma sector in 1981 by setting up a small Bulk drugs plant at Surendranagar in Gujarat, to cater to the need of Pharma industry for Quality Products. The Bulk Drugs Industry at that point of time was highly dependent on costly imports and the growth was not achievable. The Company gradually formed a vertically integrated industry chain covering Drug Intermediates, Active Pharma Ingredients (APIs), excipients and finished dosage forms. The Group has 3 manufacturing facilities located in Gujarat, 2 for APIs and drug intermediates (at Ahmedabad and Surendranagar) and 1 for finished pharmaceutical formulations (at Mehsana). Thereafter, the Company set up a project to manufacture bulk drugs at Sanand, in the Ahmedabad district of Gujarat with an installed capacity of 408 tpa. Commercial production commenced in Jan.`95. It established an in-house R&D laboratory which has developed a highly improved process technology for norfloxacin, which was implemented in the plant during Oct.`95. The Company in 2009 undertook a small expansion cum-debottlenecking project; it upgraded many existing equipments.
Ishita Drugs & Industries share price as on 25 Jun 2025 is Rs. 83.75. Over the past 6 months, the Ishita Drugs & Industries share price has decreased by 2.62% and in the last one year, it has increased by 22.12%. The 52-week low for Ishita Drugs & Industries share price was Rs. 62.35 and 52-week high was Rs. 104.75.
524400
INE806D01016
Sep
Ishita Drugs & Industries Ltd FAQs
You can buy Ishita Drugs & Industries Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Ishita Drugs & Industries Ltd Share.
Company share prices and volatile and keep changing according to the market conditions. As of Jun 24, 2025 04:01 PM the closing price of Ishita Drugs & Industries Ltd was Rs.83.75.
The latest PE ratio of Ishita Drugs & Industries Ltd as of Jun 24, 2025 04:01 PM is 25.69
The latest PB ratio of Ishita Drugs & Industries Ltd as of Jun 24, 2025 04:01 PM is 0.48
The 52-week high of Ishita Drugs & Industries Ltd share price is Rs. 104.75 while the 52-week low is Rs. 62.35
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of Jun 24, 2025 04:01 PM, the market cap of Ishita Drugs & Industries Ltd stood at Rs. 25.04 Cr.
Market Outlook
View allWe appreciate your patience. Your content is on the way.